Target price | $51.80 |
Course | $34.82 |
Price potential |
48.77%
register free of charge
|
Number of estimates | 5 |
5 Analysts have issued a price target Neoleukin Therapeutics Inc 2025 .
The average Neoleukin Therapeutics Inc target price is $51.80.
This is
48.77%
register free of charge
$65.00
86.67%
register free of charge
$44.00
26.36%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Neoleukin Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Neoleukin Therapeutics Inc share has an average upside potential 2025 of
48.77%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -2.83 | -4.39 |
172.12% | 55.12% | |
P/E ratio | negative |
3 Analysts have issued a Neoleukin Therapeutics Inc forecast for earnings per share. The average Neoleukin Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Neoleukin Therapeutics Inc...
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.